Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bárbara Alonso is active.

Publication


Featured researches published by Bárbara Alonso.


American Journal of Reproductive Immunology | 2012

Intravenous Immunoglobulin Treatment Increased Live Birth Rate in a Spanish Cohort of Women with Recurrent Reproductive Failure and Expanded CD56+ Cells

Manuela Moraru; J. Carbone; Diana Alecsandru; Marcela Castillo-Rama; Aurea García-Segovia; Juana Gil; Bárbara Alonso; Angel Aguaron; Rocío Ramos-Medina; Juan Martı́nez de Marı́a; Desamparados Oliver-Miñarro; Margarita Rodríguez-Mahou; Virginia Ortega; Pedro Caballero; Elena Meliá; Juan Vidal; Malena Cianchetta-Sívori; Carmen Esteban; Loreto Vargas-Henny; Jonathan Dale; Luis Ortiz-Quintana; Eduardo Fernández-Cruz; Silvia Sánchez-Ramón

Natural killer (NK, CD3− CD56+/CD16+) and NKT‐like cells (CD3+ CD56+/CD16+) activity is considered among the key factors for reproductive success. In the absence of immunological screening, beneficial effects of intravenous immunoglobulin (IVIG) in preventing recurrent reproductive failure (RRF) have not been reported. Here, we analyse the IVIG influence on pregnancy success in women with RRF and circulating NK or/and NKT‐like cells expansion.


PLOS ONE | 2012

Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis

Clara de Andrés; Roseta Teijeiro; Bárbara Alonso; Francisco Sánchez-Madrid; M. Luisa Martínez; Juan Guzmán de Villoria; Eduardo Fernández-Cruz; Silvia Sánchez-Ramón

Myeloid and plasmacytoid dendritic cells (mDCs, pDCs) are central to the initiation and the regulation of immune processes in multiple sclerosis (MS). Natalizumab (NTZ) is a humanized monoclonal antibody approved for the treatment of MS that acts by blocking expression of VLA-4 integrins on the surface of leukocytes. We determined the proportions of circulating DC subsets and analyzed expression of VLA-4 expression in 6 relapsing-remitting MS patients treated with NTZ for 1 year. VLA-4 expression levels on pDCs and mDCs decreased significantly during follow-up. In vitro coculture of peripheral blood mononuclear cells and pDCs, with different doses of NTZ in healthy controls (HC) and MS patients showed dose-dependent down-regulation of VLA-4 expression levels in both MS patients and HC, and reduced functional ability to stimulate antigen-specific T-lymphocyte responses. The biological impact of NTZ may in part be attributable to inhibition of transmigration of circulating DCs into the central nervous system, but also to functional impairment of interactions between T cells and DC.


European Journal of Clinical Investigation | 2011

Estradiol-dependent perforin expression by human regulatory T-cells.

Larissa Valor; Roseta Teijeiro; Carol Aristimuño; Florence Faure; Bárbara Alonso; Clara de Andrés; Marta Tejera; Nieves López-Lazareno; Eduardo Fernández-Cruz; Silvia Sánchez-Ramón

Eur J Clin Invest 2011; 41 (4): 357–364


Journal of Neuroimmunology | 2014

New regulatory CD19+CD25+ B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids

Clara de Andrés; Marta Tejera-Alhambra; Bárbara Alonso; Lara Valor; Roseta Teijeiro; Rocío Ramos-Medina; Dolores Mateos; Florence Faure; Silvia Sánchez-Ramón

In multiple sclerosis (MS), the immune damage to the central nervous system results from the net balance between self-reactive and immunoregulatory cells, among other factors. We identified novel perforin-expressing regulatory B-cells (BReg) in patients with clinically isolated syndrome, significantly enriched within the cerebrospinal fluid when compared to peripheral blood, of memory B cell phenotype (CD19(+)CD25(+), CD19(+)CD25(+)FoxP3(+) and CD19(+)FoxP3(+), p=0.007, p=0.06 and p=0.03, respectively). These BReg subsets were also higher in relapsing-remitting MS during relapse symptoms than in non-clinically active MS patients. Suppressive effects by CD19(+)CD25(+hi) BReg on CD4(+) T cell proliferation seem to be mediated at least in part by perforin/granzyme pathway. To our knowledge, this is the first report that shows cytolytic perforin/granzyme granule storage in B cells; the interesting point is its involvement on BReg cell immunosuppressive mechanisms, similarly to that in TReg cells. Our data may extend the understanding of pathophysiological processes in MS immunoregulation.


American Journal of Reproductive Immunology | 2014

Experience in IVIg Therapy for Selected Women with Recurrent Reproductive Failure and NK Cell Expansion

Rocío Ramos-Medina; Aurea García-Segovia; Juana Gil; J. Carbone; Ángel Aguarón de la Cruz; Ansgar Seyfferth; Bárbara Alonso; Jorge Alonso; Juan Antonio León; Diana Alecsandru; Elena Meliá; Elena Carrillo de Albornoz; Daniel Ordoñez; Isabel Santillán; Victoria Verdú; José Ruiz de Morales; Marcos López-Hoyos; Arturo López Larios; Almudena Sampalo; Pedro Caballero; Luis Ortiz Quintana; Eduardo Fernández-Cruz; Silvia Sánchez-Ramón

Recurrent reproductive failure (RRF) has been associated with expansion of circulating NK cells, key cells for maternal tolerance, decidual vasculogenesis and embryo growth. This study reports our experience in intravenous immunoglobulin (IVIg) therapy of a large cohort of women with RRF with expanded circulating NK and/or NKT‐like cells (blood NKT cells are a heterogeneous subset of T cells that share properties of both T cells and NK cells).


Blood | 2013

Aryl hydrocarbon receptor contributes to the MEK/ERK-dependent maintenance of the immature state of human dendritic cells

Noemí Aguilera-Montilla; Chamorro S; Concha Nieto; Fátima Sánchez-Cabo; Ana Dopazo; Pedro M. Fernández-Salguero; Rodríguez-Fernández Jl; Oscar M. Pello; Andrés; Cuenda A; Bárbara Alonso; Ángeles Domínguez-Soto; Silvia Sánchez-Ramón; Angel L. Corbí

Dendritic cells (DCs) promote tolerance or immunity depending on their maturation state, which is enhanced or accelerated upon MEK-ERK signaling pathway inhibition. We have determined the contribution of MEK-ERK activation to the profile of gene expression of human immature monocyte-derived dendritic cells (MDDCs) and peripheral blood myeloid DCs. ERK inhibition altered the expression of genes that mediate Chemokine (C-C motif) ligand 19 (CCL19)-directed migration (CCR7) and low-density lipoprotein (LDL) binding (CD36, SCARB1, OLR1, CXCL16) by immature DCs. In addition, ERK upregulated CCL2 expression while impairing the expression of DC maturation markers (RUNX3, ITGB7, IDO1). MEK-ERK-regulated genes exhibited an overrepresentation of cognate sequences for the aryl hydrocarbon receptor (AhR) transcription factor, whose transcriptional and DNA-binding activities increased in MDDCs upon exposure to the MEK1/2 inhibitor U0126. Therefore, the MEK-ERK signaling pathway regulates antigen capture, lymph node homing, and acquisition of maturation-associated genes, and its contribution to the maintenance of the immature state of MDDCs and myeloid DCs is partly dependent on the activity of AhR. Since pharmacologic modulation of the MEK-ERK signaling pathway has been proposed as a potential therapeutic strategy for cancer, our findings indicate that ERK inhibitors might influence antitumor responses through regulation of critical DC effector functions.


PLOS ONE | 2015

Plasma biomarkers discriminate clinical forms of multiple sclerosis.

Marta Tejera-Alhambra; Armanda Casrouge; Clara de Andrés; Ansgar Seyfferth; Rocío Ramos-Medina; Bárbara Alonso; Janet Vega; Lidia Fernández-Paredes; Matthew L. Albert; Silvia Sánchez-Ramón

Multiple sclerosis, the most common cause of neurological disability in young population after trauma, represents a significant public health burden. Current challenges associated with management of multiple sclerosis (MS) patients stem from the lack of biomarkers that might enable stratification of the different clinical forms of MS and thus prompt treatment for those patients with progressive MS, for whom there is currently no therapy available. In the present work we analyzed a set of thirty different plasma cytokines, chemokines and growth factors present in circulation of 129 MS patients with different clinical forms (relapsing remitting, secondary progressive and primary progressive MS) and 53 healthy controls, across two independent cohorts. The set of plasma analytes was quantified with Luminex xMAP technology and their predictive power regarding clinical outcome was evaluated both individually using ROC curves and in combination using logistic regression analysis. Our results from two independent cohorts of MS patients demonstrate that the divergent clinical and histology-based MS forms are associated with distinct profiles of circulating plasma protein biomarkers, with distinct signatures being composed of chemokines and growth/angiogenic factors. With this work, we propose that an evaluation of a set of 4 circulating biomarkers (HGF, Eotaxin/CCL11, EGF and MIP-1β/CCL4) in MS patients might serve as an effective tool in the diagnosis and more personalized therapeutic targeting of MS patients.


International Journal of Molecular Sciences | 2012

Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences

Marta Tejera-Alhambra; Bárbara Alonso; Roseta Teijeiro; Rocío Ramos-Medina; Carol Aristimuño; Larissa Valor; Clara de Andrés; Silvia Sánchez-Ramón

Multiple sclerosis (MS) represents the leading cause of neurological deficit among young adults, affecting women more frequently than men. In MS, the extent of central nervous system lesions is determined by the net balance between self-reactive and regulatory T-cells at any given time, among other factors, as well as by the effect of inflammatory response. Here, we studied both CD4+ and CD8+ TReg in parallel in blood and CSF during MS relapse. A recruitment of both regulatory CD4+ and CD8+ T cells (TReg) within the cerebrospinal fluid (CSF) takes place during MS relapse. Not previously described, the presence of CD4+ TReg in CSF was higher in women than in men, which could account for the sexual dimorphism in the incidence of MS. A direct correlation between plasma oestradiol (E2) and IL-2 levels was observed, in line with a putative circuit of E2 and perforin expression by CD4+ TReg playing a role in MS. Also, serum IFN-alpha was higher in females, with direct correlation with serum E2 levels. This is the first study to analyze perforin expression by CD4+ TReg in MS, which was greatly enhanced in CSF, what points out a relevant role of this molecule in the suppressive effects of the CD4+ TReg in MS, and contributes to the understanding of MS pathophysiology.


American Journal of Reproductive Immunology | 2013

New decision-tree model for defining the risk of reproductive failure.

Rocío Ramos-Medina; Aurea García-Segovia; Juan Antonio León; Bárbara Alonso; Marta Tejera-Alhambra; Juana Gil; Juan D. Caputo; Ansgar Seyfferth; Angel Aguaron; Angeles Vicente; Daniel Ordoñez; Jorge Alonso; Elena Carrillo de Albornoz; J. Carbone; Pedro Caballero; Eduardo Fernández-Cruz; Luis Ortiz-Quintana; Silvia Sánchez-Ramón

Natural killer (NK) cells play a key role in embryo implantation and pregnancy success, whereas blood and uterine NK expansions have been involved in the pathophysiology of reproductive failure (RF). Our main goal was to design in a large observational study a tree‐model decision for interpretation of risk factors for RF.


Journal of Immunology | 2017

Palmitate Conditions Macrophages for Enhanced Responses toward Inflammatory Stimuli via JNK Activation

Marta Riera-Borrull; Víctor D. Cuevas; Bárbara Alonso; Miguel A. Vega; Jorge Joven; Elena Izquierdo; Angel L. Corbí

Obesity is associated with low-grade inflammation and elevated levels of circulating saturated fatty acids, which trigger inflammatory responses by engaging pattern recognition receptors in macrophages. Because tissue homeostasis is maintained through an adequate balance of pro- and anti-inflammatory macrophages, we assessed the transcriptional and functional profile of M-CSF–dependent monocyte-derived human macrophages exposed to concentrations of saturated fatty acids found in obese individuals. We report that palmitate (C16:0, 200 μM) significantly modulates the macrophage gene signature, lowers the expression of transcription factors that positively regulate IL-10 expression (MAFB, AhR), and promotes a proinflammatory state whose acquisition requires JNK activation. Unlike LPS, palmitate exposure does not activate STAT1, and its transcriptional effects can be distinguished from those triggered by LPS, as both agents oppositely regulate the expression of CCL19 and TRIB3. Besides, palmitate conditions macrophages for exacerbated proinflammatory responses (lower IL-10 and CCL2, higher TNF-α, IL-6, and IL-1β) toward pathogenic stimuli, a process also mediated by JNK activation. All of these effects of palmitate are fatty acid specific because oleate (C18:1, 200 μM) does not modify the macrophage transcriptional and functional profiles. Therefore, pathologic palmitate concentrations promote the acquisition of a specific polarization state in human macrophages and condition macrophages for enhanced responses toward inflammatory stimuli, with both effects being dependent on JNK activation. Our results provide further insight into the macrophage contribution to obesity-associated inflammation.

Collaboration


Dive into the Bárbara Alonso's collaboration.

Top Co-Authors

Avatar

Silvia Sánchez-Ramón

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Eduardo Fernández-Cruz

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Angel L. Corbí

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar

Concha Nieto

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar

J. Carbone

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Juana Gil

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Lidia Fernández-Paredes

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Diana Alecsandru

Complutense University of Madrid

View shared research outputs
Researchain Logo
Decentralizing Knowledge